View in EDS

Induction EGFR tyrosine kinase inhibitors prior to definitive chemoradiotherapy in unresectable stage III EGFR-mutated non-small cell lung cancer.

Saved in:
Bibliographic Details
Title: Induction EGFR tyrosine kinase inhibitors prior to definitive chemoradiotherapy in unresectable stage III EGFR-mutated non-small cell lung cancer.
Authors: Aredo JV; Department of Medicine, University of California, San Francisco, CA, 94143, USA; Division of Oncology, Department of Medicine, Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA, 94305, USA., Wakelee HA; Division of Oncology, Department of Medicine, Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA, 94305, USA., Hui AB; Department of Radiation Oncology, Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA, 94305, USA., Padda SK; Division of Oncology, Samuel Oschin Cancer Center, Cedars-Sinai Medical Center, Los Angeles, CA, 90048, USA., Joshi ND; University Healthcare Alliance, Stanford Healthcare, Newark, CA, 94560, USA., Guo HH; Department of Radiology, Stanford University School of Medicine, Stanford, CA, 94305, USA., Chaudhuri A; Department of Radiation Oncology, Washington University School of Medicine in St. Louis, St. Louis, MO, 63110, USA., Diehn M; Department of Radiation Oncology, Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA, 94305, USA., Loo BW Jr; Department of Radiation Oncology, Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA, 94305, USA., Neal JW; Division of Oncology, Department of Medicine, Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA, 94305, USA. Electronic address: jwneal@stanford.edu.
Source: Cancer treatment and research communications [Cancer Treat Res Commun] 2022; Vol. 33, pp. 100659. Date of Electronic Publication: 2022 Nov 17.
Publication Type: Journal Article
Journal Info: Publisher: Elsevier Country of Publication: England NLM ID: 101694651 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2468-2942 (Electronic) Linking ISSN: 24682942 NLM ISO Abbreviation: Cancer Treat Res Commun Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 36427429
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Induction EGFR tyrosine kinase inhibitors prior to definitive chemoradiotherapy in unresectable stage III EGFR-mutated non-small cell lung cancer.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Aredo+JV%22">Aredo JV</searchLink>; Department of Medicine, University of California, San Francisco, CA, 94143, USA; Division of Oncology, Department of Medicine, Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA, 94305, USA.<br /><searchLink fieldCode="AU" term="%22Wakelee+HA%22">Wakelee HA</searchLink>; Division of Oncology, Department of Medicine, Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA, 94305, USA.<br /><searchLink fieldCode="AU" term="%22Hui+AB%22">Hui AB</searchLink>; Department of Radiation Oncology, Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA, 94305, USA.<br /><searchLink fieldCode="AU" term="%22Padda+SK%22">Padda SK</searchLink>; Division of Oncology, Samuel Oschin Cancer Center, Cedars-Sinai Medical Center, Los Angeles, CA, 90048, USA.<br /><searchLink fieldCode="AU" term="%22Joshi+ND%22">Joshi ND</searchLink>; University Healthcare Alliance, Stanford Healthcare, Newark, CA, 94560, USA.<br /><searchLink fieldCode="AU" term="%22Guo+HH%22">Guo HH</searchLink>; Department of Radiology, Stanford University School of Medicine, Stanford, CA, 94305, USA.<br /><searchLink fieldCode="AU" term="%22Chaudhuri+A%22">Chaudhuri A</searchLink>; Department of Radiation Oncology, Washington University School of Medicine in St. Louis, St. Louis, MO, 63110, USA.<br /><searchLink fieldCode="AU" term="%22Diehn+M%22">Diehn M</searchLink>; Department of Radiation Oncology, Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA, 94305, USA.<br /><searchLink fieldCode="AU" term="%22Loo+BW+Jr%22">Loo BW Jr</searchLink>; Department of Radiation Oncology, Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA, 94305, USA.<br /><searchLink fieldCode="AU" term="%22Neal+JW%22">Neal JW</searchLink>; Division of Oncology, Department of Medicine, Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA, 94305, USA. Electronic address: jwneal@stanford.edu.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101694651%22">Cancer treatment and research communications</searchLink> [Cancer Treat Res Commun] 2022; Vol. 33, pp. 100659. <i>Date of Electronic Publication: </i>2022 Nov 17.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier%22">Elsevier </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101694651 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2468-2942 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2224682942%22">24682942 </searchLink><i>NLM ISO Abbreviation: </i>Cancer Treat Res Commun <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=36427429
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1016/j.ctarc.2022.100659
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 100659
    Titles:
      – TitleFull: Induction EGFR tyrosine kinase inhibitors prior to definitive chemoradiotherapy in unresectable stage III EGFR-mutated non-small cell lung cancer.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Aredo JV
      – PersonEntity:
          Name:
            NameFull: Wakelee HA
      – PersonEntity:
          Name:
            NameFull: Hui AB
      – PersonEntity:
          Name:
            NameFull: Padda SK
      – PersonEntity:
          Name:
            NameFull: Joshi ND
      – PersonEntity:
          Name:
            NameFull: Guo HH
      – PersonEntity:
          Name:
            NameFull: Chaudhuri A
      – PersonEntity:
          Name:
            NameFull: Diehn M
      – PersonEntity:
          Name:
            NameFull: Loo BW Jr
      – PersonEntity:
          Name:
            NameFull: Neal JW
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 01
              Text: 2022
              Type: published
              Y: 2022
          Identifiers:
            – Type: issn-electronic
              Value: 2468-2942
          Numbering:
            – Type: volume
              Value: 33
          Titles:
            – TitleFull: Cancer treatment and research communications
              Type: main
ResultId 1